The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...

VolitionRx (VNRX) announces the results of a study which shows that an automated Nu.Q Cancer immunoassay test in development detected a range ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ('Volition'), a multi-national epigenetics company, today announces the results of a study which shows that an automated Nu.Q® Cancer immunoassay test in ...

The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

QuidelOrtho QDEL recently launched the Results Manager System, a cutting-edge solution designed to streamline diagnostic data management and improve workflow efficiency in laboratories. This ...

Quick, on-the-spot drug tests, often called point-of-use or rapid tests, are designed to give a fast indication of possible ...

A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.

In addition, the increasing focus on point-of-care testing (POCT) is propelling demand for portable and easy-to-use immunoassay analysers, specifically in resource-constrained settings.

they are routinely used in nonlaboratory testing environments. Although the assay workflow enables the participation of test operators with little or no laboratory skills, proper specimen ...